Detalhe da pesquisa
1.
Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention.
Subst Abus
; 40(4): 466-468, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361588
2.
Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention.
Subst Abus
; 40(1): 4-6, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100051
3.
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice.
J Addict Med
; 16(6): 716-721, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913992
4.
'Extreme duplication' in the US FDA Adverse Events Reporting System database.
Drug Saf
; 30(6): 551-4, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17536881